Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anne-Laure Lepage"'
Autor:
François Ghiringhelli, Frederic Bibeau, Laurent Greillier, Jean-David Fumet, Alis Ilie, Florence Monville, Caroline Laugé, Aurélie Catteau, Isabelle Boquet, Amine Majdi, Erwan Morgand, Youssef Oulkhouir, Nicolas Brandone, Julien Adam, Thomas Sbarrato, Alboukadel Kassambara, Jacques Fieschi, Stéphane Garcia, Anne Laure Lepage, Pascale Tomasini, Jérôme Galon
Publikováno v:
EBioMedicine, Vol 92, Iss , Pp 104633- (2023)
Summary: Background: Anti-PD-1 and PD-L1 antibodies (mAbs) are approved immunotherapy agents to treat metastatic non-small cell lung cancer (NSCLC) patients. Only a minority of patients responds to these treatments and biomarkers predicting response
Externí odkaz:
https://doaj.org/article/af4bad0461854aff8dc0c5518a34fcbc
Autor:
Jerome Galon, Frederic Bibeau, Laurent Greillier, Jean David Fumet, Alis Ilie, Florence Monville, Caroline Laugé, Aurelie Catteau, Isabelle Boquet, Amine Majdi, Youssef Oulkhouir, Nicolas Brandone, Julien Adam, Thomas Sbarrato, Alboukadel Kassambara, Jacques Fieschi, Stephane Garcia, Anne Laure Lepage, Pascale Tomasini, François Ghiringhelli
Publikováno v:
Journal of Clinical Oncology. 40:2509-2509
2509 Background: Anti-PD1 and PD-L1 antibodies (mAb) are immune checkpoint inhibitors (ICIs) to treat patients with metastatic non–small cell lung cancer (NSCLC). Unfortunately, only a handful of patients respond to ICIs. Methods: A cohort of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b1c06ee70fd4dacfc791ca84b5c27b1
https://doi.org/10.1200/jco.2022.40.16_suppl.2509
https://doi.org/10.1200/jco.2022.40.16_suppl.2509
Autor:
Anne Janin, Anne Laure Lepage, Philippe Ratajczak, Charlotte Brugière, Laurence Verneuil, Mohammed Sy, Rachida Ait El Far, Christophe Leboeuf, Guillaume Gapihan, Morad El Bouchtaoui
Publikováno v:
Journal of Investigative Dermatology. 138:2063-2066
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcae414c95953199ba42babd33bcf6d
https://doi.org/10.1016/j.jid.2018.02.044
https://doi.org/10.1016/j.jid.2018.02.044
Autor:
Sandra Lassalle, Jean-Christophe Sabourin, Elodie Long-Mira, Julien Mazieres, Frédéric Bibeau, Michel Poudenx, Salomé Lalvée, Jonathan Benzaquen, Charles-Hugo Marquette, Jean Michel Vignaud, Paul Hofman, Simon Heeke, Hugues Begueret, Katia Zahaf, Anne-Laure Lepage, Nicolas Piton, Emmanuel Chamorey, Clémence Yguel, Marius Ilie, Véronique Hofman, Isabelle Rouquette
Publikováno v:
Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14 (7), pp.1204-1212. ⟨10.1016/j.jtho.2019.03.024⟩
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14 (7), pp.1204-1212. ⟨10.1016/j.jtho.2019.03.024⟩
Introduction The detection of a ROS1 rearrangement in advanced and metastatic lung adenocarcinoma (LUAD) led to a targeted treatment with tyrosine kinase inhibitors with favorable progression-free survival and overall survival of the patients. Thus,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f0c4f6f7d351cf59323cc36b716f53
https://hal.umontpellier.fr/hal-02421514/file/S1556086419302837.pdf
https://hal.umontpellier.fr/hal-02421514/file/S1556086419302837.pdf
Autor:
Véronique Hofman, Isabelle Rouquette, Sandra Lassalle, Simon Heeke, Jean-Christophe Sabourin, Nicolas Piton, Julien Mazières, Jean-Michel Vignaud, Clémence Yguel, Anne Laure Lepage, Frédéric Bibeau, Elodie Long-Mira, Katia Zahaf, Hugues Begueret, Jonathan Benzaquen, Michel Poudenx, Charles-Hugo Marquette, Marius Ilie, Paul Hofman
Publikováno v:
Cancer Research. 79:3127-3127
Background: The detection of a ROS1 rearrangement in advanced or metastatic lung adenocarcinoma (LUAD) lead to a targeted treatment with tyrosine kinase inhibitors with improved progression free survival (PFS) and overall survival (OS) of the patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c008c98e518659113edcc0b4034b31
https://doi.org/10.1158/1538-7445.am2019-3127
https://doi.org/10.1158/1538-7445.am2019-3127